Key result
Oral inorganic nitrate intake significantly reduced resting systolic blood pressure (-4.80 mmHg, P<0.0001) and improved endothelial function, arterial stiffness, and platelet aggregation.
Why the study?
Does oral inorganic nitrate/nitrite intake improve cardiovascular disease risk factors in humans?
Meta-Analysis
Does oral inorganic nitrate/nitrite intake improve cardiovascular disease risk factors in humans?
Oral inorganic nitrate intake represents a simple dietary strategy that significantly improves multiple cardiovascular risk factors, including blood pressure, endothelial function, and arterial stiffness.
Answers are grounded in this paper and cite their sources.
Supports inorganic nitrate as dietary adjunct for BP and vascular function; strengthens Level 1 evidence for CVD risk factor modification.
Context: Depleted nitric oxide levels in the human body play a major role in cardiovascular disease pathogenesis. Inorganic nitrate/nitrite (rich dietary sources include beetroot and spinach) can act as a nitric oxide donor because nitrate/nitrite can be metabolized to produce nitric oxide. Objective: This review and meta-analysis sought to investigate the role of inorganic nitrate/nitrite in preventing or treating cardiovascular disease risk factors in humans. Data Sources: Electronic databases, including Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane, and Scopus, were searched. Data Extraction: Experimental trials examining the effect of oral inorganic nitrate/nitrite intake on cardiovascular disease risk factors were included for systematic analysis. Results: Thirty-four studies were included for qualitative synthesis, 23 of which were eligible for meta-analysis. Included studies measured the following outcomes: blood pressure, endothelial function, arterial stiffness, platelet aggregation, and/or blood lipids. Inorganic nitrate intake was found to significantly reduce resting blood pressure (systolic blood pressure: -4.80 mmHg, P < 0.0001; diastolic blood pressure: -1.74 mmHg, P = 0.001), improve endothelial function (flow-mediated dilatation: 0.59%, P < 0.0001), reduce arterial stiffness (pulse wave velocity: -0.23 m/s, P < 0.0001; augmentation index: -2.1%, P = 0.05), and reduce platelet aggregation by 18.9% (P < 0.0001). Conclusions: Inorganic nitrate consumption represents a simple strategy for targeting cardiovascular disease risk factors. Future studies investigating the long-term effects of inorganic nitrate on cardiovascular disease outcomes are warranted.
No takes yet. Share an insight, caveat, or question.
Jackson et al. (2018) conducted a meta-analysis in Cardiovascular disease risk factors. Oral inorganic nitrate/nitrite was evaluated on Resting systolic blood pressure (MD -4.80 mmHg, p=<0.0001). Oral inorganic nitrate intake significantly reduced resting systolic blood pressure (-4.80 mmHg, P<0.0001) and improved endothelial function, arterial stiffness, and platelet aggregation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: